title: Kidney diseases and NOAC therapy: Is there a light at the end of the tunnel?
authors.affiliation: Dept. of Cardiology and Intensive Care Medicine, St. Vincenz-Krankenhaus, Paderborn, Germany; Working Group: Molecular Electrophysiology, University Hospital Magdeburg, Magdeburg, Germany.
authors.forename: Matthias
authors.initials: M
authors.lastname: Hammwöhner
authors.affiliation: Dept. of Cardiology and Intensive Care Medicine, St. Vincenz-Krankenhaus, Paderborn, Germany; Working Group: Molecular Electrophysiology, University Hospital Magdeburg, Magdeburg, Germany. Electronic address: andreas.goette@vincenz.de.
authors.forename: Andreas
authors.initials: A
authors.lastname: Goette
mesh_terms: D000925:Anticoagulants; D001281:Atrial Fibrillation; D006801:Humans; D007674:Kidney Diseases
chemical_list: D000925:Anticoagulants